Insmed (INSM) Net Margin (2010 - 2026)
Insmed's (INSM) quarterly Net Margin came in at 53.46% in Q1 2026, up 22296.0% year-on-year from N/an in Q1 2025, and up 57.06% quarter-over-quarter from 124.5% in Q4 2025.
Insmed (INSM) Net Margin (2010 - 2026) Analysis & Trends
Insmed's Net Margin history runs 12 years deep, the most recent figure standing at 53.46% for Q1 2026.
- On a quarterly basis, Net Margin rose 22296.0% year-over-year to 53.46% in Q1 2026; TTM through Mar 2026 was 144.44%, a 12149.0% increase from a year earlier, with the FY2025 full-year figure at 210.54%, up 4070.0% from the prior year.
- Net Margin rose to 53.46% in Q1 2026 per INSM's latest filing, from 124.5% in the prior quarter.
- Across five years, Net Margin topped out at 53.46% in Q1 2026 and bottomed at 332.75% in Q2 2024.
- The 5-year median for Net Margin is 225.53% (2024), against an average of 222.94%.
- Across the five-year window, Net Margin plunged 17034 bps in 2023 and jumped 22296 bps in 2026, its largest moves.
- Year by year, Net Margin stood at 270.02% in 2022, then gained by 18 bps to 222.31% in 2023, then declined by 1 bps to 225.53% in 2024, then jumped by 45 bps to 124.5% in 2025, then jumped by 57 bps to 53.46% in 2026.
- Per Business Quant, the three latest INSM Net Margin figures stand at 53.46% (Q1 2026), 124.5% (Q4 2025), and 259.95% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -53.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.46% |
| Dec 31, 2025 | -124.50% |
| Sep 30, 2025 | -259.95% |
| Jun 30, 2025 | -299.48% |
| Mar 31, 2025 | -276.42% |
| Dec 31, 2024 | -225.53% |
| Sep 30, 2024 | -236.04% |
| Jun 30, 2024 | -332.75% |
| Mar 31, 2024 | -208.07% |
| Dec 31, 2023 | -222.31% |
| Sep 30, 2023 | -201.00% |
| Jun 30, 2023 | -316.99% |
| Mar 31, 2023 | -244.98% |
| Dec 31, 2022 | -270.02% |
| Sep 30, 2022 | -193.63% |
| Jun 30, 2022 | -146.65% |
| Mar 31, 2022 | -178.17% |
| Dec 31, 2021 | -201.30% |
| Sep 30, 2021 | -241.06% |
| Jun 30, 2021 | -258.61% |